Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis

CONCLUSIONS: In our IPF cohort, we found that there was a significant delay between the onset of symptoms and diagnosis. Moreover, we identified multiple comorbidities associated with IPF, which increases the burden on both IPF patients and clinicians. Importantly, AE and the use of antifibrotic therapy were independent predictors of survival. It is of paramount importance for clinicians to diagnose IPF at an early stage, refer patients to experienced centers, recognize comorbidities, and initiate antifibrotic therapy regardless of the underlying disease severity.

Source: Annals of Thoracic Medicine - October 10, 2020 Category: Respiratory Medicine Authors: Esam H Alhamad Joseph G Cal Nuha N Alrajhi Waleed M Aharbi Ammar C AlRikabi Ahmad A AlBoukai Source Type: research